Companion Animals

Companion Dog Atopy Immunotherapy Outcomes

Long-term outcomes of allergen-specific immunotherapy for canine atopic dermatitis and factors affecting treatment success.

Key Facts

Allergen-specific immunotherapy achieves complete or significant improvement in 60-70% of dogs
Treatment requires 12-24 months of injections before full efficacy is established
Subcutaneous and sublingual routes are both effective with similar success rates
Identifying the specific allergens through intradermal or serology testing guides treatment
Dogs with single-trigger atopy respond better than those with multiple allergen sensitizations

Welfare Considerations

Atopic dermatitis causes chronic, relentless itching that profoundly reduces quality of life. Immunotherapy offers the possibility of long-term control or remission with fewer systemic drugs than symptomatic management. The investment in time and cost delivers significant welfare returns for responsive dogs.

What You Can Do

Pursue allergen-specific immunotherapy testing and treatment for dogs with moderate to severe atopy
Give immunotherapy the full 12-24 months before assessing efficacy
Combine immunotherapy with environmental allergen reduction for best outcomes